Randomization, biomarkers, endpoints, estimands, sample size requirements, random error and bias, multiple testing correction, intent-to-treat versus per-protocol, equipoise and stopping rules for trials, database development, validation and reporting/transferring, development of statistical analysis plans, considerations around missing data.